Inhibrx Biosciences
Price & Volume
Stats
See more52W Range | $12.72-$155.29 |
Market Cap | $1.5B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$100M |
Diluted EPS | -$8.39 |
News
See moreYahoo Finance • 16 days ago
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study
Yahoo Finance • 18 days ago
Merck Broadens KEYTRUDA Collaborations As Patent Expiry Pressure Builds
Yahoo Finance • last month
T-Mobile reportedly in merger talks, Adobe's $25B stock buyback
Yahoo Finance • 2 months ago
Inhibrx gains as Stifel issues new Buy based on lead assets
About
CEO | Mr. Mark Paul Lappe |
CFO | Ms. Kelly Devine Deck B.S., CPA, M.S. |
Address | 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |